{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 6,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 5,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Potential Merck $MRK Trade Has 5.78% Downside Protection",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 2,
            "Tech_Mentions": 4
        },
        {
            "News_content": "$MRK: Advaxis, Merck to test immune therapies against prostate cancer",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 7,
            "Specificity": 9,
            "Sector_Spread": 3,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$MRK received a new alert. Find out why",
            "Correlation": 7,
            "Sentiment": 5,
            "Importance": 4,
            "Impact": 3,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 5,
            "Specificity": 6,
            "Sector_Spread": 1,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @megtirrell: $PFE and $MRK to collaborate to study pembro and crizotinib in clinical trial",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        }
    ]
}